T Cell PTLD Successfully Treated With Single-Agent Brentuximab Vedotin First-Line Therapy

Title
T Cell PTLD Successfully Treated With Single-Agent Brentuximab Vedotin First-Line Therapy
Authors
Keywords
-
Journal
TRANSPLANTATION
Volume 100, Issue 3, Pages e8-e10
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2016-02-20
DOI
10.1097/tp.0000000000001099

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started